VF
IBIO icon

Virtu Financial’s iBio IBIO Stock Holding History

Virtu Financial’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,822
Closed -$21K – 1890
2026
Q1 		$21K Buy
+10,822
New +$25.1K ﹤0.01% 1392
2025
Q4 		– Sell
-41,900
Closed -$35K – 1909
2025
Q3 		$35K Buy
41,900
+1,719
+4% +$1.32K ﹤0.01% 1196
2025
Q2 		$31K Buy
+40,181
New +$43.6K ﹤0.01% 1203
2023
Q4 		– Sell
-1,622
Closed -$10K – 1759
2023
Q3 		$10K Buy
+1,622
New +$14K ﹤0.01% 1107
2023
Q2 		– Sell
-2,294
Closed -$95K – 1734
2023
Q1 		$95K Sell
2,294
-51
-2% -$1.31K 0.01% 997
2022
Q4 		$21K Buy
+2,345
New +$79.3K ﹤0.01% 1262
2022
Q3 		– Sell
-244
Closed -$32K – 1931
2022
Q2 		$32K Buy
244
+158
+184% +$23.8K ﹤0.01% 1239
2022
Q1 		$18K Sell
86
-273
-76% -$57.1K ﹤0.01% 1309
2021
Q4 		$99K Sell
359
-3
-0.8% -$1.14K 0.01% 1137
2021
Q3 		$192K Buy
+362
New +$225K 0.02% 930
2021
Q2 		– Sell
-188
Closed -$144K – 1756
2021
Q1 		$144K Buy
188
+77
+69% +$67.1K 0.01% 1196
2020
Q4 		$58K Sell
111
-461
-81% -$376K 0.01% 1200
2020
Q3 		$581K Buy
572
+491
+606% +$712K 0.1% 247
2020
Q2 		$90K Buy
+81
New +$53K 0.01% 909
2019
Q4 		$25K Buy
199
+116
+140% +$15.7K ﹤0.01% 1293
2019
Q3 		$22K Buy
83
+61
+277% +$20.5K ﹤0.01% 1281
2019
Q2 		$8K Sell
22
-13
-37% -$5.25K ﹤0.01% 1392
2019
Q1 		$15K Buy
35
+13
+59% +$5.64K ﹤0.01% 1309
2018
Q4 		$8K Buy
22
+2
+10% +$774 ﹤0.01% 1458
2018
Q3 		$9K Buy
+20
New +$8.1K ﹤0.01% 1450
2018
Q2 		– Sell
-11
Closed -$12K – 2213
2018
Q1 		$12K Buy
+11
New +$11.5K ﹤0.01% 1851
2017
Q4 		– Sell
-23
Closed -$37K – 2625
2017
Q3 		$37K Buy
+23
New +$37.1K ﹤0.01% 2265

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial's IBIO Position: Q2 2026 in Review

Virtu Financial sold out of iBio (IBIO) in Q2 2026, closing a stake of 10,822 shares — an estimated $21K sold.

Virtu Financial first reported a position in IBIO in Q3 2017 and held it in 22 quarters. The position peaked at $581K in Q3 2020. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Virtu Financial reported no remaining iBio position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 10,822 iBio shares in Q2 2026, an estimated $21K.
  • Virtu Financial first reported a position in iBio in Q3 2017 and held it in 22 quarters.
  • Virtu Financial's iBio position peaked at $581K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.